Back to search

Peptide record

TPDB41395

NMANF2 Anticancer standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41395
NMANF2
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 21-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
KAIGLVIPEIDGKLDGGAQRV
Physicochemical Analysis
C95H165N27O29
NCHMFSTWY
G
2149.52
7.04
3
3
9
+0
6.09
0.171
130.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
0
0.00
1
Residue Composition
number
2
A
1
R
0
N
2
D
0
C
1
E
1
Q
4
G
0
H
3
I
2
L
2
K
0
M
0
F
1
P
0
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 2 C: 0 E: 1 Q: 1 G: 4 H: 0 I: 3 L: 2 K: 2 M: 0 F: 0 P: 1 S: 0 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
21
C95H165N27O29
2149.52
7.04
+0
6.09
0.171
Free
L
Linear
Free
Anticancer
Staphylococcus hominis strain MANF2
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 46.6 µg/mL
Anticancer
46.6 µg/mL

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay

Source & Reference

CancerPPD 2.0
CancerPPD2
2020

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 48.9 µg/mL
Anticancer
48.9 µg/mL

Target

Colon Cancer
HT-29
Colon

Assay & Model

MTT assay

Source & Reference

CancerPPD 2.0
CancerPPD2
2020